Influence of ethnicity on IGF‐I and procollagen III peptide (P‐III‐P) in elite athletes and its effect on the ability to detect GH abuse
- 30 December 2008
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 70 (1) , 161-168
- https://doi.org/10.1111/j.1365-2265.2008.03319.x
Abstract
Context A method based on the two GH dependent markers, IGF‐I and procollagen III peptide (P‐III‐P) has been proposed to detect exogenously administered GH. As previous studies involved predominantly white European elite athletes, it is necessary to validate the method in other ethnic groups. Objective To examine serum IGF‐I and P‐III‐P in elite athletes of different ethnicities within 2 h of competing at national or international events. Design Cross‐sectional observational study. Setting National and International sporting events. Subjects 1085 elite athletes of different ethnicities. Intervention Serum IGF‐I and P‐III‐P were measured and GH‐2000 discriminant function score was calculated. Effect of ethnicity was assessed. Results In men, IGF‐I was 21·7 ± 2·6% lower in Afro‐Caribbeans than white Europeans (P < 0·0001) but there were no differences between other ethnic groups. In women, IGF‐I was 14·2 ± 5·1% lower in Afro‐Caribbeans (P = 0·005) and 15·6 ± 7·0% higher in Orientals (P = 0·02) compared with white Europeans. P‐III‐P was 15·2 ± 3·5%, 26·6 ± 6·6% and 19·3 ± 5·8% lower in Afro‐Caribbean (P < 0·0001), Indo‐Asian (P < 0·0001) and Oriental men (P = 0·001), respectively, compared with white European men. In women, P‐III‐P was 15·7 ± 4·7% lower in Afro‐Caribbeans compared to white Europeans (P =0·0009) but there were no differences between other ethnicities. Despite these differences, most observations were below the upper 99% prediction limits derived from white European athletes. All GH‐2000 scores lay below the cut‐off limit proposed for doping. Conclusions The GH‐2000 detection method based on IGF‐I and P‐III‐P would be valid in all ethnic groups.Keywords
This publication has 14 references indexed in Scilit:
- Detection of growth hormone abuse in sportGrowth Hormone & IGF Research, 2007
- Influence of Demographic Factors and Sport Type on Growth Hormone-Responsive Markers in Elite AthletesJournal of Clinical Endocrinology & Metabolism, 2006
- Serum IGF-I levels are similar in Samoan, Māori and European populations despite differences in body compositionGrowth Hormone & IGF Research, 2006
- Racial and anthropometric differences in plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein-3Urology, 2005
- Pitfalls of immunoassay and sample for IGF-I: Comparison of different assay methodologies using various fresh and stored serum samplesClinical Biochemistry, 2005
- Toward the Development of a Test for Growth Hormone (GH) Abuse: A Study of Extreme Physiological Ranges of GH-Dependent Markers in 813 Elite Athletes in the Postcompetition SettingJournal of Clinical Endocrinology & Metabolism, 2005
- Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sportcclm, 2005
- IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohortBritish Journal of Cancer, 2003
- Insulin, growth hormone and sportJournal of Endocrinology, 2001
- How Much Insulin-Like Growth Factor I (IGF-I) Circulates? Impact of Standardization on IGF-I Assay AccuracyJournal of Clinical Endocrinology & Metabolism, 1998